Related Articles
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
Accurate prognosis of patients with luminal type A and HER‑2 overexpressing breast cancer via the partitioning calculation method of the Ki‑67 index
Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer
Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma
PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma